As seen in CRS, since IL-6, IL-1, and nitric oxide (NO) secreted by recipient macrophages mediate the severity of the syndrome rather than cytokines obtained from CAR T cells, blocking IL-6 and IL-1 and inhibiting inducible NO synthase (iNOS) provides an ameliorating effect (173). Here, IL6 is linked to congenital rubella syndrome.